Cancer clinical trials in the region Bretagne
87 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT06393816
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Immunotherapy
Immunotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges), CHU de Rennes - Hôpital Pontchaillou (Rennes), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Centre Léon Bérard
Phase 2
Pancreas cancer
#NCT04325425
Neuroendocrine tumor
Metastatic
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
CHU Caen Normandie (Caen), Centre hospitalier universitaire François Mitterrand (Dijon), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier de Saint-Malo (Saint-Malo) (and 2 more...)
CHU Dijon
Phase 2
Pancreas cancer
#NCT03175224
Locally Advanced
Metastatic
Other mutation
KRAS G12C
KRAS non G12C
Other mutation
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Pancreas cancer
#NCT03915678
Metastatic
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Pancreas cancer
#NCT04976634
Adenocarcinoma
Locally Advanced
Metastatic
Chemotherapy
Immunotherapy
Targeted therapy
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Grenoble (La Tronche), Institut Sainte Catherine (Avignon), Centre Eugene Marquis (Rennes) (and 1 more...)
Merck KGaA
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Mantel cell lymphoma
CD20
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Lymphoma
#NCT05283720
B cell lymphoma
Follicular lymphoma
CD20
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Hôpital Saint Louis AP-HP (Paris), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Claude Huriez (Lille), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy) (and 5 more...)
Abbvie
Phase 2
Rectal cancer
#NCT05723562
Locally Advanced
MSI/dMMR
Systemic Treatment-Naive
MSS
Surgery
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Centre Hospitalier Universitaire de Besançon (Besançon), Institut Paoli-Calmettes (Marseille), CHU de Rennes - Hôpital Pontchaillou (Rennes), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Antoine AP-HP (Paris)
GlaxoSmithKline
Phase 2
Lung cancer
#NCT05565378
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (>= 50%)
EGFR
ALK
Immunotherapy
Centre Hospitalier de Cornouaille (Quimper), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg), Centre Hospitalier Universitaire de Bordeaux (Bordeaux), CHU Caen Normandie (Caen), Hôpital de la Timone AP-HM (Marseille)
GlaxoSmithKline